Clinical Trial Update: A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Symlin (pramlintide) in adolescents with Type 1 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Symlin (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED